Alliance A081105: Randomized Study of Erlotinib or Observation in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
Rocky Mountain Regional VA Medical Center
Study ID
Protocol Number: 19-1697
More information available at ClinicalTrials.gov: NCT02193282
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers